Clinical Trials for Steroid Refractory Graft Versus Host Disease

Find clinical trials for steroid refractory graft versus host disease. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

NCT ID: NCT04744116

This clinical trial is exploring whether adding special cells from umbilical cord blood, called cord blood tissue-derived mesenchymal stromal cells (cb-MSCs), can improve the treatment for patients...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Houston, Texas, United States

Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

NCT ID: NCT05993611

This clinical trial is studying a new treatment for patients with chronic graft-versus-host disease (cGVHD), a condition that can occur after receiving a stem cell transplant. This condition happen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions